Synovus Financial Corp Amgen Inc Transaction History

Synovus Financial Corp

$7.79 Billion
Q4 2024

A detailed history of Synovus Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Synovus Financial Corp holds 65,729 shares of AMGN stock, worth $19.9 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

65,729

Previous 65,564 0.25%

Holding current value

$19.9 Million

Previous $21.1 Million 18.91%

% of portfolio

0.22%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$258.78 - $328.31 $42,698 - $54,171	165 Added 0.25%	65,729 $17.1 Million
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $632,991 - $690,279	2,046 Added 3.22%	65,564 $21.1 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $139,520 - $169,553	531 Added 0.84%	63,518 $19.8 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $1.41 Million - $1.7 Million	-5,252 Reduced 7.7%	62,987 $17.9 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $220,399 - $273,631	1,008 Added 1.5%	68,239 $18.3 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $176,987 - $209,283	826 Added 1.24%	67,231 $14.9 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $587,731 - $716,345	2,603 Added 4.08%	66,405 $16.1 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $1.05 Million - $1.34 Million	4,602 Added 7.77%	63,802 $16.8 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $842,622 - $950,325	3,754 Added 6.77%	59,200 $13.4 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $849,012 - $944,803	3,680 Added 7.11%	55,446 $13.5 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $125,203 - $138,507	571 Added 1.12%	51,766 $12.5 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.05 Million - $1.2 Million	5,271 Added 11.48%	51,195 $11.5 Million
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $2.34 Million - $2.74 Million	11,006 Added 31.52%	45,924 $9.77 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $97,636 - $108,320	-418 Reduced 1.18%	34,918 $8.5 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $173,755 - $202,483	783 Added 2.27%	35,336 $8.78 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $1.55 Million - $1.85 Million	-7,172 Reduced 17.19%	34,553 $7.95 Million
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $420,492 - $467,622	-1,792 Reduced 4.12%	41,725 $10.6 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $1.83 Million - $2.25 Million	-9,269 Reduced 17.56%	43,517 $10.3 Million
Q1 2020 Apr 24, 2020	BUY	$182.24 - $241.7 $984,460 - $1.31 Million	5,402 Added 11.4%	52,786 $10.7 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $418,532 - $537,958	-2,212 Reduced 4.46%	47,384 $11.4 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $179,855 - $215,504	1,033 Added 2.13%	49,596 $9.61 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $1.63 Million - $1.91 Million	-9,757 Reduced 16.73%	48,563 $8.94 Million
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $258,824 - $291,752	-1,431 Reduced 2.39%	58,320 $11.1 Million
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $468,656 - $547,072	2,627 Added 4.6%	59,751 $11.6 Million
Q3 2018 Nov 01, 2018	BUY	$185.29 - $208.89 $214,380 - $241,685	1,157 Added 2.07%	57,124 $11.8 Million
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $222,673 - $250,109	1,341 Added 2.45%	55,967 $10.3 Million
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $523,538 - $611,820	3,090 Added 6.0%	54,626 $9.31 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $55,700 - $62,234	-330 Reduced 0.64%	51,536 $8.96 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $8.68 Million - $9.91 Million	51,866	51,866 $9.67 Million

Others Institutions Holding AMGN

# of Institutions

3,164

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $162B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Amgen Inc Transaction History